- Home
- YOSH vs NXL Comparison
YOSH vs NXL Comparison
Compare YOSH & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOSH
- NXL
- Stock Information
- Founded
- YOSH 2016
- NXL 2010
- Country
- YOSH United States
- NXL United States
- Employees
- YOSH N/A
- NXL N/A
- Industry
- YOSH Restaurants
- NXL Medical Specialities
- Sector
- YOSH Consumer Discretionary
- NXL Health Care
- Exchange
- YOSH Nasdaq
- NXL Nasdaq
- Market Cap
- YOSH 23.7M
- NXL 21.0M
- IPO Year
- YOSH 2022
- NXL 2022
- Fundamental
- Price
- YOSH $9.69
- NXL $0.96
- Analyst Decision
- YOSH
- NXL Strong Buy
- Analyst Count
- YOSH 0
- NXL 1
- Target Price
- YOSH N/A
- NXL $5.00
- AVG Volume (30 Days)
- YOSH 5.6K
- NXL 88.4K
- Earning Date
- YOSH 08-18-2025
- NXL 08-07-2025
- Dividend Yield
- YOSH N/A
- NXL N/A
- EPS Growth
- YOSH N/A
- NXL N/A
- EPS
- YOSH N/A
- NXL N/A
- Revenue
- YOSH $13,539,317.00
- NXL $131,065.00
- Revenue This Year
- YOSH N/A
- NXL $79.59
- Revenue Next Year
- YOSH N/A
- NXL $334.65
- P/E Ratio
- YOSH N/A
- NXL N/A
- Revenue Growth
- YOSH 41.82
- NXL N/A
- 52 Week Low
- YOSH $2.71
- NXL $0.59
- 52 Week High
- YOSH $22.50
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- YOSH 34.47
- NXL 31.63
- Support Level
- YOSH $9.19
- NXL $0.89
- Resistance Level
- YOSH $10.00
- NXL $1.05
- Average True Range (ATR)
- YOSH 0.76
- NXL 0.09
- MACD
- YOSH -0.16
- NXL -0.00
- Stochastic Oscillator
- YOSH 14.44
- NXL 21.91
About YOSH Yoshiharu Global Co.
Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.